LivaNova PLC Interest Expense 2011-2025 | LIVN

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense LivaNova PLC

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
1.01 M	-931 K	691 K	50.2 M	40.8 M	15.1 M	9.82 M	7.8 M	10.6 M	21 K	20 K	119 K	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
50.2 M	-931 K	11.3 M

Quarterly Interest Expense LivaNova PLC

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
400 K	200 K	-73 K	-	275 K	104 K	-369 K	-	15 M	-185 K	13.4 M	-	12.7 M	14.4 M	7.84 M	-	11.4 M	16.5 M	15.9 M	-	14.7 M	5.72 M	10.6 M	-	4.77 M	4.05 M	1.66 M	-	2.63 M	3.01 M	2.11 M	-	1.42 M	1.58 M	2.32 M	-	3.5 M	1.98 M	1.19 M	-	125 K	22 K	7 K	-	-7.12 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
16.5 M	-369 K	4.96 M

Interest Expense of other stocks in the Medical devices industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
Abiomed ABMD	58.7 M	-	-	$ 17.2 B	USA
Acutus Medical AFIB	5.66 M	-	-26.83 %	$ 2.62 M	USA
Allied Healthcare Products AHPI	191 K	-	3.58 %	$ 2.21 M	USA
Boston Scientific Corporation BSX	305 M	$ 96.13	0.04 %	$ 141 B	USA
Conformis CFMS	2.02 M	-	-	$ 16.4 M	USA
Cardiovascular Systems CSII	1.63 M	-	0.15 %	$ 844 M	USA
Apyx Medical Corporation APYX	2.48 M	$ 3.6	-	$ 125 M	USA
Cutera CUTR	-244 K	-	-10.19 %	$ 1.99 M	USA
Bio-Rad Laboratories BIO	48.9 M	$ 301.75	0.24 %	$ 8.51 B	USA
Apollo Endosurgery APEN	4.67 M	-	-	$ 475 M	USA
Eargo EAR	549 K	-	-	$ 10.2 M	USA
BioSig Technologies BSGM	23 K	-	37.08 %	$ 85.7 M	USA
Bruker Corporation BRKR	-38.2 M	$ 48.12	0.21 %	$ 7.17 K	USA
Abbott Laboratories ABT	376 M	$ 124.81	0.22 %	$ 217 B	USA
EDAP TMS S.A. EDAP	232 K	$ 2.97	4.58 %	$ 111 M	France
Neovasc NVCN	133 K	-	-	$ 111 M	Canada
IRadimed Corporation IRMD	164 K	$ 97.06	0.48 %	$ 1.23 B	USA
Dynatronics Corporation DYNT	410 K	-	14.99 %	$ 929 K	USA
Cognyte Software Ltd. CGNT	-1.61 M	$ 9.54	-	$ 685 M	Israel
LENSAR LNSR	660 K	$ 12.01	-0.08 %	$ 138 M	USA
Second Sight Medical Products EYES	1.19 M	-	-0.97 %	$ 54.4 M	USA
Align Technology ALGN	7.68 M	$ 157.84	0.69 %	$ 11.8 B	USA
NanoVibronix NAOV	135 K	-	-	$ 1.08 M	USA
Accuray Incorporated ARAY	13 M	$ 0.86	0.43 %	$ 88.4 M	USA
Avinger AVGR	1.72 M	-	-20.74 %	$ 369 K	USA
ClearPoint Neuro CLPT	-40 K	$ 14.49	0.84 %	$ 392 M	USA
FONAR Corporation FONR	347 K	$ 14.53	0.07 %	$ 95.2 M	USA
Myomo MYO	21.1 K	$ 1.02	12.09 %	$ 7.19 M	USA
AxoGen AXGN	-199 K	$ 32.64	-0.61 %	$ 1.44 B	USA
Axonics Modulation Technologies AXNX	-2.43 M	-	-	$ 3.31 B	USA
CONMED Corporation CNMD	37.3 M	$ 40.17	1.34 %	$ 1.24 B	USA
NuVasive NUVA	-21.4 M	-	-	$ 2.07 B	USA
OrthoPediatrics Corp. KIDS	-1.07 M	$ 17.41	0.75 %	$ 402 M	USA
Globus Medical GMED	2.2 M	$ 88.43	-0.38 %	$ 12 B	USA
Integra LifeSciences Holdings Corporation IART	3.94 M	$ 12.66	0.56 %	$ 975 M	USA